|
1
|
Jiang WG and Ablin RJ: Cancer metastasis,
challenges, progress and the opportunities. Front Biosci (Elite
Ed). 3:391–394. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kitamura T, Qian BZ and Pollard JW: Immune
cell promotion of metastasis. Nat Rev Immunol. 15:73–86. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Smith HA and Kang YT: The
metastasis-promoting roles of tumor-associated immune cells. J Mol
Med (Berl). 91:411–429. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fridman WH, Pages F, Sautes-Fridman C and
Galon J: The immune contexture in human tumours: Impact on clinical
outcome. Nat Rev Cancer. 12:298–306. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zlotnic A and Yoshie O: The chemokine
superfamily revisited. Immunity. 36:705–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Almeida FF and Belz GT: Innate lymphoid
cells: Models of plasticity for immune homeostasis and rapid
responsiveness in protection. Mucosal Immunol. 9:1103–1112. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Corrado C, Raimondo S, Chiesi A, Ciccia F,
De Leo G and Alessandro R: Exosomes as intercellular signaling
organelles involved in health and disease: Basic science and
clinical applications. Int J Mol Sci. 14:5338–5366. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang CM, Ploia C, Anselmi F, Sarukhan A
and Viola A: Adenosine triphosphate acts as a paracrine signaling
molecule to reduce the motility of T cells. EMBO J. 33:1354–1364.
2014.PubMed/NCBI
|
|
9
|
Fidler IJ: Lymphocytes are not only
immunocytes. Biomedicine. 32:1–3. 1980.PubMed/NCBI
|
|
10
|
Senovilla L, Galluzzi L, Zitvogel L and
Kroemer G: Immunosurveillance as a regulator of tissue homeostasis.
Trends Immunol. 34:471–481. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hu W and Pasare C: Location, location,
location: Tissue-specific regulation of immune responses. J Leukoc
Biol. 94:409–421. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shechter R, London A and Schwartz M:
Orchestrated leukocyte recruitment to immune-privileged sites:
Absolute barriers versus educational gates. Nat Rev Immunol.
13:206–218. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Schaerli P, Ebert L, Willimann K, Blaser
A, Roos RS, Loetscher P and Moser B: A skin-selective homing
mechanism for human immune surveillance T cells. J Exp Med.
199:1265–1275. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Satija R and Shalek AK: Heterogeneity in
immune responses: From populations to single cells. Trends Immunol.
35:219–229. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Caramalho I, Nunes-Cabaco H, Foxall RB and
Sousa AE: Regulatory T-cell development in the human thymus. Front
Immunol. 6:3952015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ge Q, Hu H, Eisen HN and Chen J: Different
contributions of thymopoiesis and homeostasis-driven proliferation
to the reconstitution of naive and memory T cell compartments. Proc
Natl Acad Sci USA. 99:2989–2994. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chinn IK, Blackburn CC, Manley NR and
Semprowski GD: Changes in primary lymphoid organs with aging. Semin
Immunol. 24:309–320. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ucar O, Li K, Dvornicov D, Kreutz C,
Timmer J, Matt S, Brenner L, Smedley S, Travis MA, Hoffman TG, et
al: A thymic epithelial stem cell pool persists throughout ontogeny
and is modulated by TGF-β. Cell Rep. 17:448–457. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hsieh CS, Lee HM and Lio CW: Selection of
regulatory T cells in the thymus. Nat Rev Immunol. 12:157–567.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Dobrzanski MJ: Expanding roles for CD4 T
cells and their subpopulations in tumor immunity and therapy. Front
Oncol. 3:632013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
von Boehmer H: The thymus in immunity and
in malignancy. Cancer Immunol Res. 2:592–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong J, Chen Y, Xu X, Jin R, Teng F, Yan
F, Tang H, Li P, Sun X, Li Y, et al: Homeostatic properties and
phenotypic maturation of murine CD4+ pre-thymic
emigrants in the thymus. PLoS One. 8:e563782013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Munoz MA, Biro M and Weninger W: T cell
migration in intact lymph nodes in vivo. Curr Opin Cell Biol.
30:17–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Singh NK, Riley TP, Baker SCB, Borrman T,
Weng Z and Baker BM: Emerging concepts in TCR specificity:
Rationalizing and (maybe) predicting outcomes. J Immunol.
199:2203–2213. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Parrish HL, Deshpande NR, Vasic J and
Kuhns MS: Functional evidence for TCR-intrinsic specificity for
MHCII. Proct Natl Acad Sci USA. 113:3000–3005. 2016. View Article : Google Scholar
|
|
26
|
Sethna Z, Elhanati Y, Dudgeon CS, Callan
CG Jr, Levine AJ, Mora T and Walczak AM: Insights into immune
system development and function from mouse T-cell repertoires. Proc
Natl Acad Sci USA. 114:2253–2258. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Muller WA: How endothelial cells regulate
transmigration of leukocytes in the inflammatory response. Am J
Pathol. 184:886–896. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Anders HJ, Romagnani P and Mantovani A:
Pathomechanisms: Homeostatic chemokines in health, tissue
regeneration, and progressive diseases. Trends Mol Med. 20:154–165.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thiault N, Darrigues J, Adoue V, Gros M,
Binet B, Perals C, Leobon B, Fazilleau N, Joffre OP, Robey EA, et
al: Peripheral regulatory T lymphocytes recirculating to the thymus
suppress the development of their precursors. Nat Immunol.
16:628–634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Farber DL, Yudanin NA and Restifo NP:
Human memory T cells: Generation, compartmentalization and
homeostasis. Nat Rev Immunol. 14:24–35. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Halkias J, Melichar HJ, Taylor KT and
Robey EA: Tracking migration during human T cell development. Cell
Mol Life Sci. 71:3101–3117. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Dominguez GA, Anderson NR and Hammer DA:
The direction of migration of T-lymphocytes under flow depends upon
which adhesion receptors are engaged. Integr Biol (Camb).
7:345–355. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mrass P, Petravic J, Davenport MP and
Weninger W: Cell-autonomous and environmental contributions to the
interstitial migration of T cells. Semin Immunopathol. 32:257–274.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ruddle NH: Lymphatic vessels and tertiary
lymphoid organs. J Clin Invest. 124:953–959. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Mai J, Virtue A, Shen J, Wang H and Yang
XF: An evolving new paradigm: Endothelial cells-conditional innate
immune cells. J Hematol Oncol. 6:612013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Smigiel KS, Srivastava S, Stolley JM and
Campbell DJ: Regulatory T-cell homeostasis: Steady-state
maintenance and modulation during inflammation. Immunol Rev.
259:40–59. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Feinerman O, Jentsch G, Tkach KE, Coward
JW, Hathorn MM, Sneddon MW, Emonet T, Smith KA and Altan-Bonnet G:
Single-cell quantification of IL-2 response by effector and
regulatory T cells reveals critical plasticity in immune response.
Mol Syst Biol. 6:4372010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Barbi J, Pardoll D and Pan F: Treg
functional stability and its responsiveness to the
microenvironment. Immunol Rev. 259:115–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Zhan Y, Bourges D, Dromey JA, Harrison LC
and Lew AM: The origin of thymic CD4+CD25+
regulatory T cells and their co-stimulatory requirements are
determined after elimination of recirculating peripheral
CD4+ cells. Int Immunol. 19:455–463. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Mittelbrunn M and Sánchez-Madrid F:
Intercellular communication: Diverse structures for exchange of
genetic information. Nat Rev Mol Cell Biol. 13:328–335. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Mittelbrunn M, Gutierrez-Vazquez C,
Villarroya-Beltri C, Gonzalez S, Sanchez-Cabo F, González MÁ,
Bernad A and Sanchez-Madrid F: Unidirectional transfer of
microRNA-loaded exosomes from T cells to antigen-presenting cells.
Nat Commune. 2:2822011. View Article : Google Scholar
|
|
42
|
Azmi AS, Bao B and Sarkar FH: Exosomes in
cancer development, metastasis, and drug resistance: A
comprehensive review. Cancer Metastasis Rev. 32:623–642. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yáñez-Mó M, Siljander PR, Andreu Z, Zavec
AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J,
et al: Biological properties of extracellular vesicles and their
physiological functions. J Extracell Vesicles. 4:270662015.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Green DR, Droin N and Pinkoski M:
Activation-induced cell death in T cells. Immunol Rev. 193:70–81.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ventimiglia LN and Alonso MA: Biogenesis
and function of T cell-derived exosomes. Front Cell Dev Biol.
4:842016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang Q, Jiang D, Harfuddin Z, Cheng K, Moh
MC and Schwarz H: Regulation of myelopoiesis by CD137L signaling.
Int Rev Immunol. 33:454–469. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Medler TR and Coussens LM: Duality of the
immune response in cancer: Lessons learned from skin. J Invest
Dermatol. 134:E23–E28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Savage PA, Leventhal DS and Malchow S:
Shaping the repertoire of tumor-infiltrating effector and
regulatory T cells. Immunol Rev. 259:245–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Seyfried TN and Huysentruyt LC: On the
origin of cancer metastasis. Crit Rev Oncog. 18:43–73. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Keskinov AA and Shurin MR: Myeloid
regulatory cells in tumor spreading and metastasis. Immunobiology.
220:236–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kovács KA, Hegedus B, Kenessey I and Tímár
J: Tumor type-specific and skin region-selective metastasis of
human cancers: Another example of the ‘seed and soil’ hypothesis.
Cancer Metastasis Rev. 32:493–499. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ben-Baruch A: Organ selectivity in
metastasis: Regulation by chemokines and their receptors. Clin Exp
Metastasis. 25:345–356. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Satelli A, Mitra A, Brownlee Z, Xia X,
Bellister S, Overman MJ, Kopetz S, Ellis LM, Meng QH and Li S:
Epithelial-mesenchymal transitioned circulating tumor cells capture
for detecting tumor progression. Clin Cancer Res. 21:899–906. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Dasgupta A, Lim AR and Ghajar CM:
Circulating and disseminated tumor cells: Harbingers or initiators
of metastasis? Mol Oncol. 11:40–61. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Caceres G, Puskas JA and Magliocco AM:
Circulating tumor cells: A window into tumor development and
therapeutic effectiveness. Cancer Control. 22:167–176. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Caixeiro NJ, Kienzle N, Lim SH, Spring KJ,
Tognela A, Scott KF, de Souza P and Becker TM: Circulating tumour
cells-a bona fide cause of metastatic cancer. Cancer Metastasis
Rev. 33:747–756. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Sceneay J, Smyth MJ and Möller A: The
pre-metastatic niche: Finding common ground. Cancer Metastasis Rev.
32:449–464. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Paduch R: The role of lymphangiogenesis
and angiogenesis in tumor metastasis. Cell Oncol (Dordr).
39:397–410. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Coso S, Bovay E and Petrova TV: Pressing
the right buttons: Signaling in lymphangiogenesis. Blood.
123:2614–2624. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Pietras K and Östman A: Hallmarks of
cancer: Interactions with the tumor stroma. Exp Cell Res.
316:1324–1331. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Spano D and Zollo M: Tumor
microenvironment: A main actor in the metastasis process. Clin Exp
Metastasis. 29:381–395. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Spinella F, Caprara V, Cianfrocca R,
Rosanò L, Di Castro V, Garrafa E, Natali PG and Bagnato A: The
interplay between hypoxia, endothelial and melanoma cells regulates
vascularization and cell motility through endothelin-1 and vascular
endothelial growth factor. Carcinogenesis. 35:840–848. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Re RN and Cook JL: An intracrine view of
angiogenesis. Bioessays. 28:943–953. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Egeblad M, Nakasone ES and Werb Z: Tumors
as organs: Complex tissues that interface with the entire organism.
Dev Cell. 18:884–901. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wolf D, Sopper S, Pircher A, Gastl G and
Wolf AM: Treg(s) in cancer: Friends or foe? J Cell Physiol.
230:2598–2605. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Nishikawa H and Sakaguchi S: Regulatory T
cells in tumor immunity. Int J Cancer. 127:759–767. 2010.PubMed/NCBI
|
|
67
|
Bhatia A and Kumar Y: Cellular and
molecular mechanisms in cancer immune escape: A comprehensive
review. Expert Rev Clin Immunol. 10:41–62. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Dyck L and Mills KHG: Immune checkpoints
and their inhibition in cancer and infectious diseases. Eur J
Immunol. 47:765–779. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Curiel TJ: Regulatory T cells and
treatment of cancer. Curr Opin Immunol. 20:241–246. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
deLeeuw RJ, Kost SE, Kakal JA and Nelson
BH: The prognostic value of FoxP3+ tumor-infiltrating
lymphocytes in cancer: A critical review of the literature. Clin
Cancer Res. 18:3022–3029. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Mailloux AW and Young MR: Regulatory
T-cell trafficking: From thymic development to tumor-induced immune
suppression. Crit Rev Immunol. 30:435–447. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
De Visser KE, Eichten A and Coussens LM:
Paradoxical roles of the immune system during cancer development.
Nat Rev Cancer. 6:24–37. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Quail DF and Joyce JA: Microenvironmental
regulation of tumor progression and metastasis. Nat Med.
19:1423–1437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Josefowicz SZ, Lu LF and Rudensky AY:
Regulatory T cells: Mechanisms of differentiation and function.
Annu Rev Immunol. 30:531–564. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Struchko GY, Меrkulova LМ and Moskvichev
YV: Morphological and immunohistochemical characteristics of the
thymus during chemical carcinogenesis induced by
1,2-dimethylhydrazine administration. Morfologiia. 146:35–39.
2014.(In Russian). PubMed/NCBI
|
|
76
|
Hamidinia M, Ghafourian Boroujerdnia M,
Talaiezadeh A, Solgi G, Roshani R, Iranprast S and Khodadadi A:
Increased P-35, EBI3 transcripts and other Treg markers in
peripheral blood mononuclear cells of breast cancer patients with
different clinical stages. Adv Pharm Bull. 5:261–267. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Lee JH, Chen Y, Chan JL, Qian YW and
Goydos JS: Molecular analysis of melanoma-induced sentinel lymph
node immune dysfunction. Cancer Immunol Immunother. 60:685–692.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Lagios MD: Clinical significance of
immunohistochemically detectable epithelial cells in sentinel lymph
node and bone marrow in breast cancer. J Surg Oncol. 83:1–4. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Vasco C, Canazza A, Rizzo A, Mossa A,
Corsini E, Silvani A, Fariselli L, Salmaggi A and Ciusani E:
Circulating T regulatory cells migration and phenotype in
glioblastoma patients: An in vitro study. J Neurooncol.
115:353–363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Zhang X, Kelaria S, Kerstetter J and Wang
J: The functional and prognostic implications of regulatory T cells
in colorectal carcinoma. J Gastrointest Oncol. 6:307–313.
2015.PubMed/NCBI
|
|
81
|
Protti MP, De Monte L and Di Lullo G:
Tumor antigen-specific CD4+ T cells in cancer immunity:
From antigen identification to tumor prognosis and development of
therapeutic strategies. Tissue Antigens. 83:237–246. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Chen X and Oppenheim JJ: Resolving the
identity myth: Key markers of functional
CD4+FoxP3+ regulatory T cells. Int
Immunopharmacol. 11:1489–1496. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Ladoire S, Arnould L, Apetoh L, Coudert B,
Martin F, Chauffert B, Fumoleau P and Ghiringhelli F: Pathologic
complete response to neoadjuvant chemotherapy of breast carcinoma
is associated with the disappearance of tumor-infiltrating
Foxp3+ regulatory T cells. Clin Cancer Res.
14:2413–2420. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Teng MW, Ngiow SF, von Scheidt B,
McLaughlin N, Sparwasser T and Smyth MJ: Conditional regulatory
T-cell depletion releases adaptive immunity preventing
carcinogenesis and suppressing established tumor growth. Cancer
Res. 70:7800–7809. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Liu Y, Gu Y and Cao X: The exosomes in
tumor immunity. Oncoimmunology. 4:e10274722015. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Bersanelli M and Buti S: From targeting
the tumor to targeting the immune system: Transversal challenges in
oncology with the inhibition of the PD-1/PD-L1 axis. World J Clin
Oncol. 8:37–53. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Dolan DE and Gupta S: PD-1 pathway
inhibitors: Changing the landscape of cancer immunotherapy. Cancer
Control. 21:231–237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Rei M, Pennington DJ and Silva-Santos B:
The emerging protumor role of γδ T lymphocytes: Implications for
cancer immunotherapy. Cancer Res. 75:798–802. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Pennock GK and Chow LQ: The evolving role
of immune checkpoint inhibitors in cancer treatment. Oncologist.
20:812–822. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Zhu J, Powis de Tenbossche CG, Cane S,
Colau D, van Baren N, Lurquin C, Schmitt-Verhulst AM, Liljestrom P,
Uyttenhove C and Van den Eynde BJ: Resistance to cancer
immunotherapy mediated by apoptosis of tumor-infiltrating
lymphocytes. Nat Commun. 8:14042017. View Article : Google Scholar : PubMed/NCBI
|
